Hui Zhao, PhD

Peer-Reviewed Articles

1. Jackson, I, Lei, X, Zhao, H, Murthy, RK, Giordano, SH, Chavez Mac Gregor, M. Racial and ethnic disparities in neoadjuvant chemotherapy patterns and outcomes in early-stage HER2-positive breast cancer. npj Breast Cancer 11(1), 2025. e-Pub 2025. PMID: 41350291.
2. Hernandez M, Maki KG, Zhao H, Toumazis I, Volk RJ. Lung Cancer Screening among Adults Older than Medicare's Upper Age Eligibility Criteria. Cancer Prev Res (Phila) 18(11):693-702, 2025. e-Pub 2025. PMID: 40625204.
3. Canavan ME, Cheng L, Xiang JJ, Lin JK, Hui D, Zhao H, Nortje N, Ratan R, Cherny N, Pham T, Giordano SH, Niu J, Adelson KB. Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality. J Clin Oncol 43(31):3391-3402, 2025. e-Pub 2025. PMID: 41004691.
4. Xiang, JJ, Cheng, L, Canavan, ME, Lin, JK, Hui, D, Ratan, R, Flowers, CR, Niu, J, Zhao, H, Giordano, SH, Adelson, K. Association of systemic anticancer treatment (SACT) with end-of-life (EOL) healthcare use among older patients with hematologic malignancies. JCO Oncology Practice 21:306, 2025. e-Pub 2025.
5. Lobo, N, Duan, Z, Sood, A, Zhao, H, Lindskrog, SV, Dyrskjøt, L, Giordano, SH, Williams, SB, Bree, KK, Kamat, A. Sex Disparity in Non-muscle-invasive Bladder Cancer. European Urology Oncology 8(3):608-611, 2025. e-Pub 2025. PMID: 39448349.
6. Karim, MA, Zhang, N, Zhao, H, Shih, YT, Kodali, LS, Giordano, SH, Shete, S. Trends in Medicare payments within the first year of cervical cancer diagnosis, 2010-2019. JNCI Cancer Spectrum 9(3), 2025. e-Pub 2025. PMID: 40238225.
7. Ruiz, JI, Zhao, B, Palaskas, NL, Deswal, A, Zhao, H, McQuade, JL, Suarez-Almazor, M. Major Adverse Cardiovascular Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitors. Journal of Immunotherapy and Precision Oncology 8(2):1-9, 2025. e-Pub 2025. PMID: 40224298.
8. Zhao, H, Shen, C, Laureano, JJ, Lei, X, Niu, J, Giordano, SH, Chavez Mac Gregor, M. Real-world neoadjuvant and adjuvant Trastuzumab-containing regimen patterns and their association with survival among patients with operable HER2-positive breast cancer from 2007 to 2021. Breast Cancer Research and Treatment 210(1):191-203, 2025. e-Pub 2025. PMID: 39576449.
9. Adjei, N, Haas, A, Sun, CC, Zhao, H, Yeh, PG, Giordano, SH, Toumazis, I, Meyer, LA. Healthcare Costs in the United States by Demographic Characteristics and Comorbidity Status. Value in Health 28(2):206-214, 2025. e-Pub 2025. PMID: 39532216.
10. Adjei, N, Haas, A, Sun, CC, Zhao, H, Yeh, PG, Giordano, SH, Toumazis, I, Meyer, LA. Cost of ovarian cancer by the phase of care in the United States. American journal of obstetrics and gynecology 232(2):204.e1-204.e13, 2025. e-Pub 2025. PMID: 39159781.
11. Adjei, N, Haas, A, Zhao, H, Primm, K, Giordano, SH, Sun, CC, Meyer, LA. Real-world trends in the use of maintenance therapy in ovarian cancer across the United States from 2017 to 2021. Gynecologic oncology 190:255-261, 2024. e-Pub 2024. PMID: 39260122.
12. Ruiz, JI, Lei, X, Chi-Fang, W, Giordano, SH, Zhao, H, Rajan, SS, Lin, HY, Suarez-Almazor, M. Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors. Breast Cancer 31(6):1059-1070, 2024. e-Pub 2024. PMID: 39117793.
13. Suarez-Almazor, M, Ruiz, JI, Lei, X, Wu, C, Zhao, H, Rajan, SS, Giordano, SH. Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer. Clinical Rheumatology 43(11):3301-3312, 2024. e-Pub 2024. PMID: 39230743.
14. Lobo, N, Duan, Z, Sood, A, Tan, WS, Grajales, V, Contieri, R, Lindskrog, SV, Dyrskjøt, L, Zhao, H, Giordano, SH, Williams, SB, Bree, KK, Kamat, A. Association of Age with Non-muscle-invasive Bladder Cancer. European Urology Oncology 7(5):1069-1079, 2024. e-Pub 2024. PMID: 38302322.
15. Lobo, N, Duan, Z, Sood, A, Tan, WS, Grajales, V, Contieri, R, Lindskrog, SV, Dyrskjøt, L, Zhao, H, Giordano, SH, Williams, SB, Bree, KK, Kamat, A. Association of Age with Non-muscle-invasive Bladder Cancer. European Urology Oncology 7(5):1069-1079, 2024. e-Pub 2024. PMID: 38302322.
16. Ye, C, Zhao, B, Leslie, WD, Ruiz, JI, Zhao, H, Hassan, NA, Suarez-Almazor, M. Increase in major osteoporotic fractures after therapy with immune checkpoint inhibitors. BMJ Oncology 3(1), 2024. e-Pub 2024. PMID: 39886118.
17. Primm, K, Zhao, H, Adjei, N, Sun, CC, Haas, A, Meyer, LA, Chang, S. Effect of Medicaid expansion on cancer treatment and survival among Medicaid beneficiaries and the uninsured. Cancer medicine 13(13), 2024. e-Pub 2024. PMID: 38970338.
18. Ruiz, JI, Lei, X, Wu, C, Zhao, H, Giordano, SH, Rajan, SS, Suarez-Almazor, M. Utilization of Biologic Disease-Modifying Antirheumatic Therapy in Patients With Rheumatoid Arthritis and Recently Diagnosed Breast Cancer. Arthritis Care and Research 76(6):850-859, 2024. e-Pub 2024. PMID: 38268474.
19. Thornton, JD, Varisco, TJ, Patel, H, Shrestha, M, Wanat, M, Schaefer, E, Leslie, D, Zhao, H, Saadi, RA, Shen, C. Characterising incident opioid use among incident users of prescription sedative hypnotics. BMJ open 14(5), 2024. e-Pub 2024. PMID: 38816043.
20. Gordon MJ, Duan Z, H Z, Nastoupil L, Ng S, Danilov AV, Iyer S, Giordano SH. Influence of treatment intensity and medical comorbidities in older adults with peripheral T cell lymphoma. Leuk Lymphoma 64(14):2258-2268, 2023. e-Pub 2023. PMID: 37706491.
21. Raber M, Rechis R, LaRue DM, Ho-Pham TT, Oestman K, Walsh MT, Kizub D, Ma H, Galvan E, H Z, Gonzalez J, Lei X, Hu J, Basen-Engquist K. Enhancing the utilization of healthy living interventions among cancer survivors in historically underserved populations and communities. Cancer Causes Control 34(8):635-645, 2023. e-Pub 2023. PMID: 37160832.
22. Gordon MJ, Duan Z, Zhao H, Nastoupil L, Ferrajoli A, Danilov AV, Giordano SH. A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale. Blood Adv 7(11):2632-2642, 2023. e-Pub 2023. PMID: 36753602.
23. Chavez-MacGregor M, Lei X, Malinowski C, Zhao H, Shih YC, Giordano SH. Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer. J Natl Cancer Inst 115(6):644-651, 2023. e-Pub 2023. PMID: 36794921.
24. Vranes C, Zhao H, Noer MC, Fu S, Sun CC, Harrison R, Ramirez PT, Høgdall CK, Giordano SH, Meyer LA. Secondary validation of an ovarian cancer-specific comorbidity index in a US population. Int J Gynecol Cancer 33(5):749-754, 2023. e-Pub 2023. PMID: 36863760.
25. Shen C, Li N, Zhou S, Stahl K, Dodge D, Zhao H. Endocrine therapy initiation and overall survival outcomes with omission of radiation therapy in older Medicare patients with early-stage hormone-receptor-positive breast cancer. Cancer Med 12(6):6935-6944, 2023. e-Pub 2023. PMID: 36428284.
26. Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LA. Medicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer: A Difference-in-Difference Analysis. Ann Surg Oncol 30(3):1508-1519, 2023. e-Pub 2023. PMID: 36310311.
27. Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LA. ASO Visual Abstract: Medicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer-A Difference-in-Difference Analysis. Ann Surg Oncol 30(3):1520-1521, 2023. e-Pub 2023. PMID: 36289120.
28. Sun SX, Duan Z, Kuerer HM, DeSnyder SM, Cunningham C, Zhao H, Giordano SH. ASO Visual Abstract: Predictors of Emergency Room Visits After Ambulatory Breast Cancer Surgery in the Medicare Population. Ann Surg Oncol 30(3):1699, 2023. e-Pub 2023. PMID: 36622528.
29. Bruera S, Lei X, Pundole X, Zhao H, Giordano SH, Vinod S, Suarez-Almazor ME. Systemic Lupus Erythematosus is a Risk Factor for Mortality in Elderly Patients with Early Breast Cancer. Arthritis Care Res (Hoboken) 75(3):559-568, 2023. e-Pub 2023. PMID: 34558796.
30. Sun SX, Duan Z, Kuerer HM, DeSnyder SM, Cunningham C, Zhao H, Giordano SH. Predictors of Emergency Room Visits After Ambulatory Breast Cancer Surgery in the Medicare Population. Ann Surg Oncol 30(3):1689-1698, 2023. e-Pub 2023. PMID: 36402898.
31. Hensley PJ, Duan Z, Bree K, Sood A, Zhao H, Lobo N, Contieri R, Campbell MT, Guo CC, Navai N, Williams SB, Dinney CP, Kamat AM. Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship. Urol Oncol 41(2):108.e11-108.e17, 2023. e-Pub 2023. PMID: 36404232.
32. Jones E, Duan Z, Nguyen TT, Giordano SH, Zhao H. Adjuvant 5-Fluorouracil/leucovorin, capecitabine, and oxaliplatin-related regimens for stage II/III colon cancer patients 66?years or older. Cancer Med 12(3):2389-2406, 2023. e-Pub 2023. PMID: 36229957.
33. Bruera S, Lei X, Zhao H, Yazdany J, Chavez-MacGregor M, Giordano SH, Suarez-Almazor ME. Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus. Lupus Sci Med 10(1), 2023. e-Pub 2023. PMID: 36787921.
34. Primm KM, Huepenbecker SP, Zhao H, Sun CC, Hernandez DC, Meyer LA, Chang S. Impacts of Medicaid Expansion on Stage at Cancer Diagnosis by Patient Insurance Type. Am J Prev Med 63(6):915-925, 2022. e-Pub 2022. PMID: 35871117.
35. Huepenbecker SP, Fu S, Sun CC, Zhao H, Primm KM, Giordano SH, Meyer LA. Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis. Am J Obstet Gynecol 227(3):482.e1-482.e15, 2022. e-Pub 2022. PMID: 35500609.
36. Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Rauh-Hain JA, Fleming ND, Giordano SH, Meyer LA. Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States. Int J Gynecol Cancer 32(9):1153-1163, 2022. e-Pub 2022. PMID: 36166208.
37. Primm KM, Zhao H, Hernandez DC, Chang S. Disparities in Early-Stage Breast Cancer and Survival-Reply. Cancer Epidemiol Biomarkers Prev 31(9):1868, 2022. e-Pub 2022. PMID: 36052486.
38. Primm, K, Zhao, H, Hernandez, DC, Chang, S. Racial and Ethnic Trends and Disparities in NSCLC. JTO Clinical and Research Reports 3(8), 2022. e-Pub 2022. PMID: 35898298.
39. Li, C, Fu, Y, Li, Q, Yang, X, Wang, W, Jin, X, Bian, L, Zhao, H, Li, D, Gao, J, Du, N, Peng, L. Postoperative high-density lipoprotein cholesterol level. Frontiers in Oncology 12, 2022. e-Pub 2022. PMID: 35924162.
40. Malinowski C, Lei X, Zhao H, Giordano SH, Chavez-MacGregor M. Association of Medicaid Expansion With Mortality Disparity by Race and Ethnicity Among Patients With De Novo Stage IV Breast Cancer. JAMA Oncol 8(6):863-870, 2022. e-Pub 2022. PMID: 35389432.
41. Lu Z, Zhang N, Giordano SH, Zhao H. Opioid use and associated factors among pancreatic cancer patients diagnosed between 2007 and 2015. Cancer Med 11(11):2296-2307, 2022. e-Pub 2022. PMID: 35199472.
42. Bruera S, Lei X, Blau B, Zhao H, Deswal A, Yazdany J, Giordano SH, Suarez-Almazor ME. Postoperative Major Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus. ACR Open Rheumatol 4(6):511-519, 2022. e-Pub 2022. PMID: 35294107.
43. Primm KM, Zhao H, Hernandez DC, Chang S. A contemporary analysis of racial and ethnic disparities in diagnosis of early stage breast cancer and stage-specific survival by molecular subtype. Cancer Epidemiol Biomarkers Prev 31(6):1185-1194, 2022. e-Pub 2022. PMID: 35314859.
44. Suarez-Almazor ME, Pundole X, Cabanillas G, Lei X, Zhao H, Elting LS, Lopez-Olivo MA, Giordano SH. Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer. JAMA Netw Open 5(4):e225432, 2022. e-Pub 2022. PMID: 35363269.
45. Huepenbecker SP, Sun CC, Fu S, Zhao H, He W, Primm K, Giordano SH, Meyer LA. Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States. Int J Gynecol Cancer 32(7):899-905, 2022. e-Pub 2022. PMID: 35331992.
46. Huepenbecker SP, Zhao H, Sun CC, Fu S, He W, Giordano SH, Meyer LA. Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data. JCO Clin Cancer Inform 6:e2100187, 2022. e-Pub 2022. PMID: 35297648.
47. Chavez-MacGregor M, Lei X, Zhao H, Scheet P, Giordano SH. Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer. JAMA Oncol 8(1):69-78, 2022. e-Pub 2022. PMID: 34709356.
48. Manzano JM, Lin H, Zhao H, Halm J, Suarez-Almazor ME. Derivation and Validation of the Cancer READMIT Score: A Readmission Risk Scoring System for Patients With Solid Tumor Malignancies. JCO Oncol Pract 18(1):OP2001077, 2022. e-Pub 2022. PMID: 34357793.
49. Oke O, Niu J, Chavez-MacGregor M, Zhao H, Giordano SH. Adjuvant tamoxifen adherence in men with early-stage breast cancer. Cancer 128(1):59-64, 2022. e-Pub 2022. PMID: 34597415.
50. Zhao H, Duan Z, Li M, Chiao E, Ahmed S, Shih YT, Hwang JP. Increased Incidence of Human Papillomavirus-Related Precancer or Second Malignancy Among Allogeneic Stem Cell Transplantation Patients: A SEER-Medicare Population Study. Transplant Cell Ther 27(12):1016.e1-1016.e9, 2021. e-Pub 2021. PMID: 34474166.
51. Bruera S, Lei X, Zogala R, Pundole X, Zhao H, Giordano SH, Hwang JP, Rauh-Hain JA, Suarez-Almazor ME. Cervical Cancer Screening in Women with Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 73(12):1796-1803, 2021. e-Pub 2021. PMID: 32799430.
52. Huepenbecker SP, Sun CC, Fu S, Zhao H, Primm K, Giordano SH, Meyer LA. Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States. Cancer 127(22):4151-4160, 2021. e-Pub 2021. PMID: 34347287.
53. Karpes Matusevich AR, Duan Z, Zhao H, Lal LS, Chan W, Suarez-Almazor ME, Giordano SH, Swint JM, Lopez-Olivo MA. Treatment sequences after discontinuing a tumor necrosis factor inhibitor in patients with rheumatoid arthritis. A comparison of cycling versus swapping strategies. Arthritis Care Res (Hoboken) 73(10):1461-1469, 2021. e-Pub 2021. PMID: 32558339.
54. Shih YT, Xu Y, Zhao H, Schrag D, Yao J. Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market. JNCI Cancer Spectr 5(4):pkab045, 2021. e-Pub 2021. PMID: 34350376.
55. Tamirisa N, Lei X, Caudle AS, Giordano SH, Zhao H, Chavez-MacGregor M. Impact of SSO-ASTRO "No Ink on Tumor" Guidelines on Reexcision Rates among Older Breast Cancer Patients. Ann Surg Oncol 28(7):3703-3713, 2021. e-Pub 2021. PMID: 33225394.
56. Harrison RF, Fu S, Sun CC, Zhao H, Lu KH, Giordano SH, Meyer LA. Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer. Am J Obstet Gynecol 225(1):68.e1-68.e11, 2021. e-Pub 2021. PMID: 33549538.
57. Zhao H, Lei X, Niu J, Zhang N, Duan Z, Chavez-MacGregor M, Giordano SH. Prescription Patterns, Initiation, and 5-Year Adherence to Adjuvant Hormonal Therapy Among Commercially Insured Patients With Breast Cancer. JCO Oncol Pract 17(6):e794-e808, 2021. e-Pub 2021. PMID: 33596096.
58. CMKL Y, Fu S, Tam S, Kiong KL, Guo T, Zhao H, Giordano SH, Sturgis EM, Lewis CM. Impact of provider type and number of providers on surveillance testing among survivors of head and neck cancers. Cancer 127(10):1699-1711, 2021. e-Pub 2021. PMID: 33471396.
59. Lu H, Lei X, Zhao H, Elting L, Siricilla M, Ursani MA, Giordano SH, Suarez-Almazor M. Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy Is Associated With Decreased Fractures in Women With Breast Cancer. J Bone Miner Res 36(5):861-871, 2021. e-Pub 2021. PMID: 33484602.
60. Zhao H, Xu Y, Huo J, Burks AC, Ost DE, Shih YT. Updated Analysis of Complication Rates Associated With Invasive Diagnostic Procedures After Lung Cancer Screening. JAMA Netw Open 3(12):e2029874, 2020. e-Pub 2020. PMID: 33326023.
61. Sharma M, Duan Z, Zhao H, Giordano SH, Chavez-MacGregor M. Real-World Patterns of Everolimus Use in Patients with Metastatic Breast Cancer. Oncologist 25(11):937-942, 2020. e-Pub 2020. PMID: 32476216.
62. Smith-Graziani D, Lei X, Giordano SH, Zhao H, Karuturi M, Chavez-MacGregor M. Delayed initiation of adjuvant chemotherapy in older women with breast cancer. Cancer Med 9(19):6961-6971, 2020. e-Pub 2020. PMID: 32767723.
63. Shen C, Thornton JD, Gu D, Dodge D, Zhou S, He W, Zhao H, Giordano SH. Prolonged Opioid Use After Surgery for Early-Stage Breast Cancer. Oncologist 25(10):e1574-e1582, 2020. e-Pub 2020. PMID: 32390251.
64. Dottino JA, He W, Sun CC, Zhao H, Fu S, Rauh-Hain JA, Suidan RS, Lu KH, Giordano SH, Meyer LA. National trends in bowel and upper abdominal procedures in ovarian cancer surgery. Int J Gynecol Cancer 30(8):1195-1202, 2020. e-Pub 2020. PMID: 32616627.
65. Suarez-Almazor ME, Herrera R, Lei X, Chavez-MacGregor M, Zhao H, Giordano SH. Survival in older women with early stage breast cancer receiving low-dose bisphosphonates or denosumab. Cancer. e-Pub 2020. PMID: 32573777.
66. Sharma M, Johnson ML, Zhao H, Giordano SH, Holmes HM. Concordance Between Electronic Health Record Data and Medicare Part D Claims Data for Oral Anticancer Drug Use. JAMA Netw Open 3(4):e203821, 2020. e-Pub 2020. PMID: 32352527.
67. Harrison R, Zhao H, Sun CC, Fu S, Armbruster SD, Westin SN, Rauh-Hain JA, Lu KH, Giordano SH, Meyer LA. Body mass index and attitudes towards health behaviors among women with endometrial cancer before and after treatment. Int J Gynecol Cancer 30(2):187-192, 2020. e-Pub 2020. PMID: 31843871.
68. Kantor O, Niu J, Zhao H, Giordano SH, Hunt KK, King TA, Mittendorf EA, Chavez-MacGregor M. Comparative Analysis of Proposed Strategies for Incorporating Biologic Factors into Breast Cancer Staging. Ann Surg Oncol. e-Pub 2020. PMID: 31916091.
69. Fu S, Wang M, Zhao H, Li R, Lairson DR, Giordano SH, Zhao B, Du XL. Comparative Effectiveness of Chemotherapy, Rituximab, and Bendamustine in Medicare Beneficiaries With Mantle-Cell Lymphoma. Clin Lymphoma Myeloma Leuk 19(11):e616-e623, 2019. e-Pub 2019. PMID: 31563564.
70. Ost DE, Niu J, Zhao H, Grosu HB, Giordano SH. Quality Gaps and Comparative Effectiveness in Lung Cancer Staging and Diagnosis. Chest. e-Pub 2019. PMID: 31610159.
71. Wang JR, Nurgalieva Z, Fu S, Tam S, Zhao H, Giordano SH, Hutcheson KA, Lewis CM. Utilization of rehabilitation services in patients with head and neck cancer in the United States: A SEER-Medicare analysis. Head Neck 41(9):3299-3308, 2019. e-Pub 2019. PMID: 31240808.
72. Suidan RS, He W, Sun CC, Zhao H, Rauh-Hain JA, Fleming ND, Lu KH, Giordano SH, Meyer LA. Total and out-of-pocket costs of different primary management strategies in ovarian cancer. Am J Obstet Gynecol 221(2):136.e1-136.e9, 2019. e-Pub 2019. PMID: 30965052.
73. Harrison RF, He W, Fu S, Zhao H, Sun CC, Suidan RS, Woodard TL, Rauh-Hain JA, Westin SN, Giordano SH, Meyer LA. National Patterns of Care and Fertility Outcomes for Reproductive-aged Women with Endometrial Cancer or Atypical Hyperplasia. Am J Obstet Gynecol. e-Pub 2019. PMID: 31128110.
74. Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LA. National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer. Gynecol Oncol 152(3):439-444, 2019. e-Pub 2019. PMID: 30876486.
75. Taylor JS, Zhang N, Rajan SS, Chavez-MacGregor M, Zhao H, Niu J, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH. How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients. Gynecol Oncol 152(3):452-458, 2019. e-Pub 2019. PMID: 30876488.
76. Hutcheson KA, Nurgalieva Z, Zhao H, Gunn GB, Giordano SH, Bhayani MK, Lewin JS, Lewis CM. Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis. Head Neck 41(2):479-487, 2019. e-Pub 2019. PMID: 30536748.
77. Taylor JS, He W, Harrison R, Zhao H, Sun CC, Lu KH, Giordano SH, Meyer LA. Disparities in treatment and survival among elderly ovarian cancer patients. Gynecol Oncol 151(2):269-274, 2018. e-Pub 2018. PMID: 30253875.
78. Meyer LA, He W, Sun CC, Zhao H, Wright AA, Suidan RS, Dottino J, Alejandro Rauh-Hain J, Lu KH, Giordano SH. Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness. Gynecol Oncol 150(3):451-459, 2018. e-Pub 2018. PMID: 29961559.
79. Deshmukh AA, Zhao H, Das P, Chiao EY, You YN, Franzini L, Lairson DR, Swartz MD, Giordano SH, Cantor SB. Clinical and Economic Evaluation of Treatment Strategies for T1N0 Anal Canal Cancer. Am J Clin Oncol 41(7):626-631, 2018. e-Pub 2018. PMID: 27755059.
80. Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, Ramondetta L, Parker SL, Suarez-Almazor ME, Ferrajoli A, Shih YT, Giordano SH, Chiao EY. Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant. Biol Blood Marrow Transplant 24(5):1094-1098, 2018. e-Pub 2018. PMID: 29378304.
81. Manzano JM, Yang M, Zhao H, Elting LS, George MC, Luo R, Suarez-Almazor ME. Readmission Patterns After GI Cancer Hospitalizations: The Medical Versus Surgical Patient. J Oncol Pract 14(3):e137-e148, 2018. e-Pub 2018. PMID: 29443648.
82. Rosenstock AS, Niu J, Giordano SH, Zhao H, Wolff AC, Chavez-MacGregor M. Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients. Cancer 124(5):899-906, 2018. e-Pub 2018. PMID: 29236294.
83. Zhao H, Zhang N, Ho V, Ding M, He W, Niu J, Yang M, Du XL, Zorzi D, Chavez-MacGregor M, Giordano SH. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011. Cancer 124(4):679-687, 2018. e-Pub 2018. PMID: 29140558.
84. Deshmukh AA, Zhao H, Franzini L, Lairson DR, Chiao EY, Das P, Swartz MD, Giordano SH, Cantor SB. Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States. Am J Clin Oncol 41(2):121-127, 2018. e-Pub 2018. PMID: 26523440.
85. Ost DE, Niu J, Zhao H, Grosu HB, Giordano SH. Quality Gaps and Comparative Effectiveness of Management Strategies for Recurrent Malignant Pleural Effusions. Chest 153(2):438-452, 2018. e-Pub 2018. PMID: 28864054.
86. Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA. Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer. Int J Gynecol Cancer 27(7):1350-1359, 2017. e-Pub 2017. PMID: 28574929.
87. Zhao H, Hei N, Wu Y, Chan W, Lei X, Cameron C, Chang S, Chavez-MacGregor M, Giordano SH. Initiation of and adherence to tamoxifen and aromatase inhibitor therapy among elderly women with ductal carcinoma in situ. Cancer 123(6):940-947, 2017. e-Pub 2017. PMID: 27780311.
88. Suidan RS, He W, Sun CC, Zhao H, Fleming ND, Ramirez PT, Soliman PT, Westin SN, Lu KH, Giordano SH, Meyer LA. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol 145(1):55-60, 2017. e-Pub 2017. PMID: 28131529.
89. Nayak P, Luo R, Elting L, Zhao H, Suarez-Almazor ME. Impact of Rheumatoid Arthritis on the Mortality of Elderly Patients who Develop Cancer: A Population-Based Study. Arthritis Care Res (Hoboken) 69(1):75-83, 2017. e-Pub 2017. PMID: 27483088.
90. Giordano SH, Niu J, Chavez-MacGregor M, Zhao H, Zorzi D, Shih YT, Smith BD, Shen C. Estimating regimen-specific costs of chemotherapy for breast cancer: Observational cohort study. Cancer. e-Pub 2016. PMID: 27723214.
91. Ho V, Ku-Goto MH, Zhao H, Hoffman KE, Smith BD, Giordano SH. Regional differences in recommended cancer treatment for the elderly. BMC Health Serv Res 16:262, 2016. e-Pub 2016. PMID: 27417075.
92. He W, Zhao H, Chan W, Lopez D, Shroff RT, Giordano SH. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer. Surgery 158(5):1226-34, 2015. e-Pub 2015. PMID: 26138347.
93. Li N, Xu L, Zhao H, El-Naggar AK, Sturgis EM. A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry. Cancer 118(16):3945-53, 2012. e-Pub 2012. PMID: 22179977.
94. Zhao H, Tektiridis JH, Zhang N, Chamberlain RM. Cancer prevention health services research: an emerging field. J Cancer Educ 27 Suppl 2(2 Suppl):S149-56, 2012. e-Pub 2012. PMID: 22311693.
95. Cheng L, Swartz MD, Zhao H, Kapadia AS, Lai D, Rowan PJ, Buchholz TA, Giordano SH. Hazard of recurrence among women after primary breast cancer treatment--a 10-year follow-up using data from SEER-Medicare. Cancer Epidemiol Biomarkers Prev 21(5):800-9, 2012. e-Pub 2012. PMID: 22426147.
96. Cameron C, Zhao H, McHugh MK. Perspective: publication ethics and the emerging scientific workforce: understanding "plagiarism" in a global context. Acad Med 87(1):51-4, 2012. e-Pub 2012. PMID: 22104051.
97. Barcenas CH, Zhang N, Zhao H, Duan Z, Buchholz TA, Hortobagyi GN, Giordano SH. Anthracycline regimen adherence in older patients with early breast cancer. Oncologist 17(3):303-11, 2012. e-Pub 2012. PMID: 22371383.
98. Yu H, Zhao H, Wang LE, Liu Z, Li D, Wei Q. Correlation between base-excision repair gene polymorphisms and levels of in-vitro BPDE-induced DNA adducts in cultured peripheral blood lymphocytes. PLoS One 7(7):e40131, 2012. e-Pub 2012. PMID: 22792228.
99. Chavez-MacGregor M, Zhao H, Kroll M, Fang S, Zhang N, Hortobagyi GN, Buchholz TA, Shih YC, Giordano SH. Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. Ann Oncol 22(11):2394-402, 2011. e-Pub 2011. PMID: 21393379.
100. Chavez-MacGregor M, Zhao H, Fang S, Srokowski TP, Hortobagyi GN, Giordano SH. Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study. Cancer 117(16):3641-9, 2011. e-Pub 2011. PMID: 21656514.
101. Yu H, Zhao H, Wang LE, Han Y, Chen WV, Amos CI, Rafnar T, Sulem P, Stefansson K, Landi MT, Caporaso N, Albanes D, Thun M, McKay JD, Brennan P, Wang Y, Houlston RS, Spitz MR, Wei Q. An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs. DNA Repair (Amst) 10(4):398-407, 2011. e-Pub 2011. PMID: 21296624.
102. Wei S, Niu J, Zhao H, Liu Z, Wang LE, Han Y, Chen WV, Amos CI, Rafnar T, Sulem P, Stefansson K, Landi MT, Caporaso NE, Albanes D, Thun MJ, McKay JD, Brennan P, Wang Y, Houlston RS, Spitz MR, Wei Q. Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study. Carcinogenesis 32(4):507-15, 2011. e-Pub 2011. PMID: 21292647.
103. Guan X, Yin M, Wei Q, Zhao H, Liu Z, Wang LE, Yuan X, O'Reilly MS, Komaki R, Liao Z. Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer 10:431, 2010. e-Pub 2010. PMID: 20712888.
104. Wei S, Liu Z, Zhao H, Niu J, Wang LE, El-Naggar AK, Sturgis EM, Wei Q. A single nucleotide polymorphism in the alcohol dehydrogenase 7 gene (alanine to glycine substitution at amino acid 92) is associated with the risk of squamous cell carcinoma of the head and neck. Cancer 116(12):2984-92, 2010. e-Pub 2010. PMID: 20336794.
105. Li C, Lu J, Liu Z, Wang LE, Zhao H, El-Naggar AK, Sturgis EM, Wei Q. The six-nucleotide deletion/insertion variant in the CASP8 promoter region is inversely associated with risk of squamous cell carcinoma of the head and neck. Cancer Prev Res (Phila) 3(2):246-53, 2010. e-Pub 2010. PMID: 20086182.
106. Guan X, Zhao H, Niu J, Tang D, Ajani JA, Wei Q. The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer. BMC Gastroenterol 9:77, 2009. e-Pub 2009. PMID: 19835575.
107. Guan X, Zhao H, Niu J, Tan D, Ajani JA, Wei Q. Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J Exp Clin Cancer Res 28:94, 2009. e-Pub 2009. PMID: 19566948.
108. Li C, Zhao H, Hu Z, Liu Z, Wang LE, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wei Q. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum Mutat 29(12):1443-51, 2008. e-Pub 2008. PMID: 18563783.
109. Chen K, Zhao H, Hu Z, Wang LE, Zhang W, Sturgis EM, Wei Q. CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 14(19):6343-9, 2008. e-Pub 2008. PMID: 18829519.
110. Zhao H, Wang LE, Li D, Chamberlain RM, Sturgis EM, Wei Q. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis. Carcinogenesis 29(8):1560-6, 2008. e-Pub 2008. PMID: 18635523.
111. Zhai X, Zhao H, Liu Z, Wang LE, El-Naggar AK, Sturgis EM, Wei Q. Functional variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell carcinoma of the oral cavity and oropharynx. Clin Cancer Res 14(13):4345-52, 2008. e-Pub 2008. PMID: 18594018.
112. Wang LE, Xiong P, Zhao H, Spitz MR, Sturgis EM, Wei Q. Chromosome instability and risk of squamous cell carcinomas of head and neck. Cancer Res 68(11):4479-85, 2008. e-Pub 2008. PMID: 18519711.

Invited Articles

1. Zhao H, Chang S. Use of oral conjugated estrogen alone and risk of breast cancer. Breast Diseases: A Year Book Quarterly 18(4):344, 2008. e-Pub 2008.

Other Articles

1. Huepenbecker, S, Fu, S, Sun, CC, Zhao, H, Primm, K, Giordano, SH, Meyer, LA Medicaid Expansion and 2-Year Survival in Women With Gynecologic Cancer. Obstetrical and Gynecological Survey 77(12):737-738, 2022.

Abstracts

1. Harrison H, Noer MC, Hogdall C, Fu S, Zhao H, Sun CC, Lu KH, Giordano SH, Meyer LA. Secondary validation of an ovarian cancer-specific comorbidity index in a US population. SGO 2020 Annual Meeting on Women’s Cancer, Toronto, CA, 2020. e-Pub 2020.
2. Harrison R, Zhao H, Fu S, Sun CC, Westin SN, Giordano SH, Meyer LA. Is an endometrial cancer diagnosis a “teachable moment” leading to weight loss among obese 3 women? A case-control study. SGO 2020 Annual Meeting on Women’s Cancer, Toronto, CA, 2020. e-Pub 2020.
3. Harrison R, Fu S, Sun CC, Zhao H, Lu K, Giordano SH, Meyer LA. Out-of-pocket costs for PARP inhibitor treatment. SGO 2020 Annual Meeting on Women’s Cancer, Toronto, CA, 2020. e-Pub 2020.
4. Lu Z, Ganduglia Cazaban C, LeonNovelo C, Yennu S, Giordano SH, Zhao H. Opioid usage patterns among Medicare pancreatic cancer patients according to palliative care utilization. Supportive Care in Oncology Symposium, San Francisco, CA, 2019. e-Pub 2019.
5. Nguyen T, Duan Z, Zhao H. Cost-effectiveness of colorectomy and adjuvant chemotherapy as treatment for stage II/III colon cancer patients. MD Anderson Summer Experience Symposium, Houston, 2019. e-Pub 2019.
6. Harrison RF, He W, Fu S, Zhao H, Sun CC, Suidan RS, Woodard TL, Rauh-Hain JA, Westin SN, Giordano SH, Meyer LA. National Patterns of Care and Fertility Outcomes for Reproductive-aged Women with Endometrial Cancer or Hyperplasia with Atypia, 1999-2014. SGO 50th Annual Meeting on Women’s Cancer, Honolulu, 2019. e-Pub 2019. PMID: 31128110.
7. Harrisonlow R, Zhao H, He W, Sun CCL, Suidan RS, Armbruster S, Rauh-Hain JA, Lu KH, Giordano SH, Meyer LA. Body mass index and intention for health behavior change before and after treatment of endometrial cancer. SGO 50th Annual Meeting on Women’s Cancer, Honolulu, 2019. e-Pub 2019.
8. Lu Z, Ganduglia Cazaban CM, LeonNovelo LG, Yennu S, Conway SH, Highfield LD, Giordano SH, Zhao H. Community-based Palliative Care and End-of-Life Care in Elderly Patients with Pancreatic Cancer. Palliative and Supportive Care in Oncology Symposium, San Diego, CA, 2018. e-Pub 2018.
9. Karpes A, Duan Z, Zhao H, Lal L, Chan W, Suárez-Almazor M, Giordano S, Swint J, Lopez-Olivo M. Treatment sequences, effectiveness, and costs of tumor necrosis factor inhibitor cycling compared with swapping to a novel disease-modifying anti-rheumatic drug in rheumatoid arthritis patients. 2019 ACR/APR Annual Meeting, Atlanta, 2018. e-Pub 2018.
10. Lu Z, Ganduglia Cazaban CM, LeonNovelo LG, Yennu S, Conway SH, Highfield LD, Giordano SH, Zhao H. Palliative Care Utilization and Its Association with Survival among Elderly Pancreatic Cancer Patients. American Public Health Association Annual Meeting, San Diego, CA, 2018. e-Pub 2018.
11. Tang E, Liu WT, Zhao H. Trends in Estrogen Receptor Positive Ductal Carcinoma in situ Patients from the Surveillance, Epidemiology, and End Results Cancer Repository. MD Anderson Summer Experience Symposium, Houston, 2018. e-Pub 2018.
12. Dottino J, He W, Sun CC, Zhao H, Lu KH, Meyer L. Patients as healthcare consumers: National patient satisfaction surveys and correlation with gynecologic cancer surgical quality. 2018 ASCO Annual Meeting, Chicago, IL, 2018. e-Pub 2018.
13. Oke O, Niu J, Chavez-MacGregor M, Zhao H, Giordano SH. Adjuvant Tamoxifen Adherence in Men with Early Stage Breast Cancer. 2018 ASCO Annual Meeting, Chicago, IL, 2018. e-Pub 2018.
14. Zhao H, Lei X, Chavez-MacGregor M, He W, Niu J, Giordano SH. Adherence to hormonal therapy among commercially insured breast cancer patients. 2018 ASCO Annual Meeting, Chicago, IL, 2018. e-Pub 2018.
15. Pena RAH, Lei X, Chavez-MacGregor M, Zhao H, Giordano SH, Suarez-Almazor ME. Overall survival in female Medicare beneficiaries with early stage breast cancer receiving bisphosphonates or denosumab. 2018 ASCO Annual Meeting, Chicago, IL, 2018. e-Pub 2018.
16. Lu Z, Ganduglia Cazaban CM, LeonNovelo LG, Yennu S, Conway SH, Highfield LD, Giordano SH, Zhao H. Community-based palliative Care Utilization in Elderly Pancreatic Cancer Patients. 2018 ASCO Annual Meeting, Chicago, IL, 2018. e-Pub 2018.
17. Dottino JA, He W, Sun CCL, Zhao H, Rauh-Hain JA, Suidan RS, Lu KH, Giordano SH, Meyer LA. Aggressive surgery in the elderly: national trends and outcomes associated with bowel and upper abdominal procedures in ovarian cancer surgery. SGO 49th Annual Meeting on Women’s Cancer, New Orleans, 2018. e-Pub 2018.
18. Lewis C, Nurgalieva Z, Gunn GB, Zhao H, Giordano SH, Bhayani M, Hutcheson KA. Trends in Head and Neck Cancer Post-Treatment Rehabilitation. American Society for Radiation Oncology Annual meeting, San Diego, 2017. e-Pub 2017.
19. Hutcheson K, Nurgalieva Z, Zhao H, Gunn GB, Giordano SH, Bhayani MK, Lewin JS, Lewis CM. 2-Year Prevalence of Dysphagia and Related Outcomes in Head and Neck Cancer Survivors: an Updated SEER-Medicare Analysis. American Society for Radiation Oncology Annual meeting, San Diego, 2017. e-Pub 2017. PMID: 30536748.
20. Liu SW, Zhao H, Giordano SH, Shen C. Occurrence and treatment of hypertension in cancer patients using VEGF inhibitors. MD Anderson Summer Experience Symposium, Houston, 2017. e-Pub 2017.
21. Suarez-Almazor M, Cabanillas G, Zhao H, Shi B, Kim JH, Elting L. Dual Energy X-ray Absorptiometry Testing in Elderly Men with Prostate Cancer Initiating Androgen Deprivation Therapy Reduces Subsequent Fracture Risk, The Annual European Congress of Rheumatology. Eular 2017 Congress Madrid, Spain, 2017. e-Pub 2017.
22. Ursani MA, Suarez-Almazor M, Yang M, Lu HF, Zhao H, Elting L. Dual Engergy X-ray Absorptiometry Testing in Women with Breast Cancer Initiating Therapy with Aromatase Inhibitors Reduces Subsequent Fracture Risk, The Annual European Congress of Rheumatology. Eular 2017 Congress Madrid, Spain, 2017. e-Pub 2017.
23. Suidan RS, He W, Sun CC, Zhao H, Lu KH, Giordano SH, Meyer L. Total and out-of-pocket costs of different primary management strategies in ovarian cancer. 2017 ASCO Annual Meeting, Chicago, 2017. e-Pub 2017.
24. Kim MJ, Duan Z, Zhao H, Holmes HM, Manzano JGM, Giordano SH, Suarez-Almazor ME. Anti-dementia and anti-hyperlipidemic medication use at end of life in elderly lung cancer patients: Analysis of SEER-Medicare data. 2017 ASCO Annual Meeting, Chicago, 2017. e-Pub 2017.
25. Rodriguez A, Cheng L, DeJesus Y, Zhao H, Giordano SH. Disease Complexity and Economic Burden on Patients with Colon Cancer in the SEER-Medicare Population. 2017 ASCO Quality Care Symposium, Orlando, Florida, 2017. e-Pub 2017.
26. Manzano JCM, Barbo AG, Lin HY, Zhao H, Halm J, Suarez-Almazor M. Readmission among patients with cancer who were discharged with hospice care. 2017 ASCO Quality Care Symposium, Orlando, Florida, 2017. e-Pub 2017.
27. Suidan RS, He W, Sun CC, Soliman PT, Ramirez PT, Zhao H, Fleming ND, Westin SN, Lu KH, Giordano SH, Meyer L. Impact of body mass index on surgical costs and morbidity for women with endometrial carcinoma/hyperplasia. 2016 ASCO Annual Meeting, Chicago, IL, 2016. e-Pub 2016.
28. Suidan RS, He W, Sun CCL, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA. Treatment patterns and outcomes for bowel obstruction in elderly ovarian cancer patients: A population-based analysis. 2016 SGO Annual Meeting, San Diego, CA, 2016. e-Pub 2016.
29. Meyer LA, He W, Sun CCL, Zhao H, Suidan RS, Lu KH, Giordano SH, Bodurka DC. Uptake and outcomes associated with neoadjuvant chemotherapy in the elderly: a population based analysis. 2016 SGO Annual Meeting, San Diego, CA, 2016. e-Pub 2016.
30. Manzano JCM, Yang M, Zhao H, Elting L, Suarez-Almazor M. 10-year trends in unplanned readmission and survival rates among patients with gastrointestinal cancer. 2016 Supportive Care in Cancer Annual Meeting, Adelaide, Australia, 2016. e-Pub 2016.
31. Mian I, Yang M, Zhao H, Mohsin S, Diab A, Shannon V, Patel A, Amaria R, Giordano SH, Suarez-Almazor M. Immune Related Adverse Events Associated with Ipilimumab. 2016 ASCO poster, Chicago, IL, 2016. e-Pub 2016.
32. Zhao H, Hei N, Wu Y, Chan W, Cameron C, Chang S, Chavez M, Giordano SH. The Use of Tamoxifen and Raloxifene among Older Women with Ductal Carcinoma in Situ. American Society of Preventive Oncology, Columbus, OH, 2016. e-Pub 2016.
33. Chavez-Mac Gregor M, He W, Zhao H, Elting L, Giordano SH. Antiemesis prophylaxis among breast cancer (BC) patients receiving highly emetogenic chemotherapy. 2015 ASCO Annual Meeting, Chicago, IL, 2015. e-Pub 2015.
34. Meyera LA, He W, Zhao H, Sun CCL, Wright A, Bodurka DC, Lu KH, Giordano SH. Patterns of care and survival in a matched case-control study of intraperitoneal chemotherapy in a national population-based cohort of elderly ovarian cancer patients. 2015 SGO Annual Meeting, Chicago, IL, 2015. e-Pub 2015.
35. Rosenstock AS, Giordano SH, Niu J, Zhao H, Wolff AC, Buchholz TA, Chavez-MacGregor M. AML and MDS after adjuvant chemotherapy: A population based study among older breast cancer patients. 2014 Annual CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, 2014. e-Pub 2014.
36. Meyer L, He W, Zhao H, Sun CC, Buchholz T, Lu KH, Giordano SH. Patterns of care and overall survival in the Medicare ovarian cancer population. 2014 ASCO Annual Meeting, Chicago, IL, 2014. e-Pub 2014.